Reference
Mylan Institutional LLC, et al. Viatris Company, Issues a Voluntary Recall of One Lot of Octreotide Acetate Injection, 500 mcg/mL, Due to Glass Particulates in a Syringe Internet Document : 3 Nov 2022. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mylan-institutional-llc-viatris-company-issues-voluntary-recall-one-lot-octreotide-acetate-injection
Rights and permissions
About this article
Cite this article
One lot of Octreotide Acetate Injection recalled due to glass particulates. Reactions Weekly 1932, 7 (2022). https://doi.org/10.1007/s40278-022-27372-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-27372-1